“Myeloma and its Precursor States: Progress Towards Prevention”

November 5, 2013

12:00PM - 1:00PM

Flyers/76er’s Theatre, White Building-Ground Floor

Brendan M. Weiss, M.D.

Associate Professor of Medicine
Hematology/Oncology Division

Target Audience

This program has been designed for departmental/institutional faculty, fellows, residents, medical students, nurses, community physicians, and allied health professionals in the medical specialties of cardiovascular medicine, endocrinology diabetes & metabolism, gastroenterology, general internal medicine, geriatrics, hematology/oncology, infectious disease, pulmonary, allergy & critical care, renal-electrolyte & hypertension, rheumatology, sleep medicine, translation medicine and human genetics.

Educational Objectives

After completing this activity, participants should be able to:

  • Learn from master clinicians about clinical problem-solving techniques
  • Review topics of important ethical or public policy implications
  • Discuss the latest advances in basic research as they relate to various clinical diseases
  • Discuss new treatment modalities for all types of diseases in internal medicine
  • Improve understanding of the pathogenesis of disease to be better able to identify adverse drug events and treatment complications

Accreditation

The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement of Commercial Support*

NONE

For more information, please contact

Denise Arnieri

215-662-2200

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, Director of CMEandthe peer reviewerZalman Agus, MD, Associate Dean for CME, have disclosed that they have norelevant financial relationships with any commercial interests related to the content of this educational activity.

The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Planning Committee Member Name

Lisa M. Bellini, MD / Richard P. Shannon, MD / Matthew Saybolt, MD
Sarah Longworth, MD / Jeffrey Thompson, MD / Laura Dingfield, MD

Presenter Name

The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.

Presenter NameName of Commercial InterestRelationship

Brendan M. Weiss, MDCelegeneConsulting
Brendan M. Weiss, MDJanssen Research and DevelopmentInvestigator
Brendan M. Weiss, MDJanssen Research and Development Advisory Board

Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected

Disclosure of Unapproved Uses of Products

Presenter nameProductInvestigational and/or Off-label Use

Brendan m. weiss, mdLenalidomide (revlimid)off-label use for smoldering myeloma
brendan m. weiss, mdsiltuximabinvestigational use for smoldering myeloma
brendan m. weiss, mdthalidomide (thalomid)investigational use for smoldering myeloma